A Capabilities, Opportunities, and Motivations behavioral analysis of healthcare professionals concerning dengue vaccination in selected countries from Latin America and Asia Pacific.
IF 4.2 4区 医学Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Andrew Green, Alberta Di Pasquale, Eduardo Lopez-Medina
{"title":"A Capabilities, Opportunities, and Motivations behavioral analysis of healthcare professionals concerning dengue vaccination in selected countries from Latin America and Asia Pacific.","authors":"Andrew Green, Alberta Di Pasquale, Eduardo Lopez-Medina","doi":"10.1080/21645515.2025.2573533","DOIUrl":null,"url":null,"abstract":"<p><p>The success of dengue vaccination programs is heavily reliant on endorsement from healthcare professionals (HCPs). This survey of 815 HCPs from Argentina, Brazil, Colombia, Indonesia, Malaysia, and Thailand aimed to identify factors associated with HCPs' willingness to recommend dengue vaccination to patients. Survey responses were mapped to six subthemes within a Capabilities, Opportunities, and Motivations behavioral framework; composite scores were calculated and correlated with willingness to recommend the dengue vaccine. Psychological Capability, Reflective Motivation, and Automatic Motivation emerged as urgent priorities based on moderate correlation with willingness to recommend the vaccine (correlation coefficients 0.50, 0.56, and 0.45, respectively) and moderate scores (57‒58%). Physical Capability was categorized as a critical strength, while Physical and Social Opportunities were lesser priorities. Targeted interventions - including HCP education, risk communication, and peer-led advocacy - are likely to improve recommendation behaviors. Addressing both individual and external drivers is essential for enabling HCPs to recommend dengue vaccination effectively.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"22 1","pages":"2573533"},"PeriodicalIF":4.2000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12851386/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2573533","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The success of dengue vaccination programs is heavily reliant on endorsement from healthcare professionals (HCPs). This survey of 815 HCPs from Argentina, Brazil, Colombia, Indonesia, Malaysia, and Thailand aimed to identify factors associated with HCPs' willingness to recommend dengue vaccination to patients. Survey responses were mapped to six subthemes within a Capabilities, Opportunities, and Motivations behavioral framework; composite scores were calculated and correlated with willingness to recommend the dengue vaccine. Psychological Capability, Reflective Motivation, and Automatic Motivation emerged as urgent priorities based on moderate correlation with willingness to recommend the vaccine (correlation coefficients 0.50, 0.56, and 0.45, respectively) and moderate scores (57‒58%). Physical Capability was categorized as a critical strength, while Physical and Social Opportunities were lesser priorities. Targeted interventions - including HCP education, risk communication, and peer-led advocacy - are likely to improve recommendation behaviors. Addressing both individual and external drivers is essential for enabling HCPs to recommend dengue vaccination effectively.
期刊介绍:
(formerly Human Vaccines; issn 1554-8619)
Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.
Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.